In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Doug Kass shares his thoughts on a strange, possibly ominous day, and a 'ludicrous forecast.'
The real story is in the stocks the pros hate.
There is no shortage of opinions and politics as the House prepares for a vote Nov. 30 on 21st Century Cures Act.
The stock will eventually rebase, but we don't know where or when.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.